The implementation of telemedicine to reduce doctor visiting in social medicine clinic Hatyai hospital.

Abstract

Background: The Pandemic of COVID-19 is the majority concern of the government to reduce the COVID-19 spread. The major measure to reduce the pandemic of COVID-19 by the government is to keep social distancing and stay at home. About 3,000 people with chronic illnesses are under the continuous care of the social medicine clinic, Hatyai hospital. Chronic illness and the Elderly are at risk of severe morbidity and mortality after being infected with Coronavirus 2019. Telemedicine is the way to replace conventional doctor-patient treatment. Objective: Reducing the number of doctor visits compared with before the implementation of telemedicine. Method: Data process mining to analyze the Frequency, Mean, and Percentage. Result: Reduced doctor visits by 10.44% compared to 2019 and 2020. Decreasing in timing in the process by 6 minutes per person without different of clinical result from hypertension and diabetes patients. Conclusion: Telemedicine help reduce doctor visits and visiting duration.

References

“อนามัยโลกตั้งชื่อ  ‘โควิด-19’  ให้โรคทางเดินหายใจจากไวรัส   สายพันธุ์ใหม่,” BBC News ไทย. Accessed:Aug.16,2022. [Online].  Available: https://www.bbc.com/thai/features-51473472

Cascella, M. Rajnik, A. Aleem, S. C. Dulebohn, and R. Di Napoli, “Features, Evaluation, and Treatment of Coronavirus (COVID-19),” in StatPearls, Treasure Island (FL):StatPearls Publishing, 2022. Accessed:Aug 16 2022. [Online].Available:http://www.ncbi.nlm.nih.govbooks/NBK554776/

Lu et al., “Genomic characterisation and epidemiolog of 2019 novel coronavirus: implications for virus origins and receptor binding,” The Lancet, vol. 395, no. 10224, pp.565–574, Feb.2020,doi:10.1016/S01406736(20)30251-8.

Kirubananthan, R. Illuri, R. Rajendran, and P. R. Chandrasekaran, “Mechanism and transmission routes of COVID-19,” Environmental and Health Management of Novel Coronavirus Disease (COVID-19 ), pp. 65–88, 2021, doi: 10.1016/B978-0-323-85780-2.00013-5.

Çalıca Utku A, Budak G, Karabay O, Güçlü E, Okan HD, Vatan A. Main symptoms in patients presenting in the COVID-19 period. Scottish Medical Journal. 2020;65(4):127-132. doi:10.1177/0036933020949253

“2017420210820025238.pdf.” Accessed: Aug. 16, 2022. [Online].  Available:  https://ddc.moph.go.th/uploads/files/2017420210820025238.pdf

“บทความสถานการณ์โรคติดเชื้อโคโรนาไวรัส 2019. pdf.”  Accessed: Aug.16,2022.[Online].Available:https://udch.go.th/uploads/doc/covid-19/บทความสถานการณ์โรคติดเชื้อโคโรนาไวรัส 2019.pdf

“media-2020-07-24-10-40-22.pdf.” Accessed: Aug. 18, 2022. [Online].  Available:  https://tmc.or.th/Media/media-2020-07-24-10-40-22.PDF

Haleem, M. Javaid, R. P. Singh., & R. Suman, “Telemedicine for healthcare: Capabilities, features, barriers, and applications,” Sensors International, vol. 2, p. 100117, Jan. 2021, doi: 10.1016/j.sintl.2021.100117.

Vidal-Alaball, J.; Franch-Parella, J.; Lopez Seguí, F.; Garcia Cuyàs, F.; Mendioroz Peña, J. Impact of a Telemedicine Program on the Reduction in the Emission of Atmospheric Pollutants and Journeys by Road. Int. J. Environ. Res. Public Health 2019, 16, 4366. https://doi.org/10.3390/ijerph16224366

บูรพา พันธ์สวัสดิ์, สิริกาญจน์ เชิดชู, อธิปัตย์ จันทร์เกษ, ปรารถนา ปุณณกิติเกษม, พงศ์พัฒน์ ตังคะประเสริฐ และ ตรีทศ เหล่าศิริหงส์ทอง. “นวัตกรรมการดูแลผู้สูงอายุผ่านระบบบริการทางไกล,” Thai Journal of Nursing Council, vol.26, pp. 5–5, 2554

Battineni., G. G.Sagaro., N. Chintalapudi., & F. Amenta. “The Benefits of Telemedicine in Personalized Prevention of Cardiovascular Diseases (CVD): A Systematic Review,” J PersMed ,vol.11 ,no.7, p.658,Jul.2021, doi:10.3390/jpm11070658.

ชวภณ กิจหิรัญกุล และวิภาวัณย์ อรรณพพรชัย. (2564). “จริยธรรมทางการแพทย์ : กรณีศึกษาการรักษาด้วยวิธีโทรเวชกรรม,” วารสารวิจัยมหาวิทยาลัย เวสเทิร์นมนุษยศาสตร์และสังคมศาสตร์, vol.7,no.3, Art.no.3,2564.

Agarwal, P. Jain, R. Pathak, and R. Gupta, “Telemedicine in India: A tool for transforming health care in the era of COVID-19 pandemic,” J Educ Health Promot, vol. 9, p. 190, Jul. 2020, doi: 10.4103/jehp.jehp_472_20.

L. Onor and S. Misan, “The clinical interview and the doctor-patient relationship in telemedicine,” Telemed J E Health, vol. 11, no. 1, pp. 102–105, Feb. 2005, doi: 10.1089/tmj.2005.11.102.

V.R.A. Call et al., “Attitudes Toward Telemedicine in Urban, Rural, and Highly Rural Communities,” Telemedicine and e-Health, vol. 21, no. 8, pp. 644–651, Aug. 2015, doi:10.1089/tmj.2014.0125.

D. Sesso et al., “Systolic and Diastolic Blood Pressure Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men,” Hypertension, vol. 36, no. 5, pp. 801–807, Nov. 2000, doi: 10.1161/01.HYP.36.5.801.

Asia Pacific Cohort Studies Collaboration, “Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis,” Hypertension, vol. 42, no. 1, pp. 69–75, Jul. 2003, doi: 10.1161/01HYP.0000075083.04415.4B.

Vantrijp, D. Grobbee, P. Peeters, Y. Vanderschouw, and M. Bots, “Average blood pressure and cardiovascular disease-related mortality in middle-aged women,” AmericanJournal of Hypertension, vol. 18, no. 2, pp. 197–201, Feb. 2005, doi: 10.1016/j.amjhyper.2004.09.005.

Elkbuli, H. Ehrlich, and M. McKenney, “The effective use of telemedicine to save lives and maintain structure in a healthcare system: Current response to COVID-19, The American Journal of Emergency Medicine, vol. 44, pp. 468–469, Jun. 2021, doi: 10.1016/j.ajem.2020.04.003.

Perrone, S. Zerbo, C. Bilotta, G. Malta, and A. Argo “Telemedicine during Covid-19 pandemic: Advantage o critical issue?,” Med Leg J, vol. 88, no. 2, pp. 76–77, Jul. 2020, doi: 10.1177/0025817220926926.